References
- Allan SE, Crome SQ, Crellin NK, et al. (2007). Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Inter Immunol, 19, 345–54
- Alvarado-Sanchez B, Hernandez-Castro B, Portales-Perez D, et al. (2006). Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun, 27, 110–18
- Ballestar E. (2010). Epigenetics lessons from twins: prospects for autoimmune disease. Clin Rev Allergy Immunol, 39, 30--41
- Baron U, Floess S, Wieczorek G, et al. (2007). DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Euro J Immunol, 37, 2378–89
- Belkaid Y, Piccirillo CA, Mendez S, et al. (2002). CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature, 420, 502–7
- Bennett CL, Christie J, Ramsdell F, et al. (2001). The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet, 27, 20–1
- Biller BJ, Elmslie RE, Burnett RC, et al. (2007). Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer. Veterin immunol Immunopathol, 116, 69–78
- Bombardier C, Gladman DD, Urowitz MB, et al. (1992). Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheumat, 35, 630–40
- Cinek T, Sadra A, Imboden JB. (2000). Cutting edge: tyrosine-independent transmission of inhibitory signals by CTLA-4. J Immunol (Baltimore, MD: 1950), 164, 5--8
- Coleman MM, Keane J, Mills KH. (2010). Editorial: Tregs and BCG--dangerous liaisons in TB. J Leukoc Biol, 88, 1067--9
- Floess S, Freyer J, Siewert C, et al. (2007). Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol, 5, e38
- Fontenot JD, Rudensky AY. (2005). A well adapted regulatory contrivance: Regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol, 6, 331–7
- Gudjonsson JE, Krueger G. (2012). A role for epigenetics in psoriasis: Methylated cytosine-guanine sites differentiate lesional from nonlesional skin and from normal skin. J Invest Dermatol, 132, 506–8
- Horwitz DA. (2008). Regulatory T cells in systemic lupus erythematosus: Past, present and future. Arthrit Res Ther, 10, 227--35
- Kole AK, Ghosh A. (2009). Cutaneous manifestations of systemic lupus erythematosus in a tertiary referral center. Ind J Dermatol, 54, 132–6
- Liu J, Lluis A, Illi S, et al. (2010). T regulatory cells in cord blood–FOXP3 demethylation as reliable quantitative marker. PLoS One, 5, e13267
- Meghari S, Bechah Y, Capo C, et al. (2008). Persistent Coxiella burnetii infection in mice overexpressing IL-10: An efficient model for chronic Q fever pathogenesis. PLoS Pathog, 4, e23
- Najafi S, Firooze Moqadam I, Mohammadzadeh M, et al. (2014). Interleukin-10 gene polymorphisms in recurrent aphthous stomatitis. Immunol investig, 43, 405–9
- Ngalamika O, Zhang Y, Yin H, et al. (2012). Epigenetics, autoimmunity and hematologic malignancies: A comprehensive review. J Autoimmun, 39, 451–65
- O’Shea JJ, Ma A, Lipsky P. (2002). Cytokines and autoimmunity. Nature reviews. Immunology, 2, 37–45
- Polansky JK, Kretschmer K, Freyer J, et al. (2008). DNA methylation controls Foxp3 gene expression. Euro J Immunol, 38, 1654–63
- Strickland FM, Richardson BC. (2008). Epigenetics in human autoimmunity. Epigenetics in autoimmunity -- DNA methylation in systemic lupus erythematosus and beyond. Autoimmunity, 41, 278--86
- Su DL, Lu ZM, Shen MN, et al. (2012). Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE. J Biomed Biotechnol, 2012, 347141
- Suarez A, Lopez P, Gomez J, Gutierrez C. (2006). Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann Rheumat Dis, 65, 1512–17
- Suri-Payer E, Fritzsching B. (2006). Regulatory T cells in experimental autoimmune disease. Springer Semin Immunopathol, 28, 3–16
- Tiwananthagorn S, Iwabuchi K, Ato M, et al. (2012). Involvement of CD4(+) Foxp3(+) regulatory T cells in persistence of Leishmania donovani in the liver of alymphoplastic aly/aly mice. PLoS Neglected Tropical Diseases, 6, e1798
- Wang J, Ioan-Facsinay A, van der Voort EI, et al. (2007). Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Euro J Immunol, 37, 129–38
- Wieczorek G, Asemissen A, Model F, et al. (2009). Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res, 69, 599–608
- Yee CS, Farewell VT, Isenberg DA, et al. (2011). The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients. Rheumatology (Oxford, England), 50, 982–8
- Young D, Hussell T, Dougan G. (2002). Chronic bacterial infections: Living with unwanted guests. Nat Immunol, 3, 1026–32
- Zhao M, Liang GP, Tang MN, et al. (2012). Total glucosides of paeony induces regulatory CD4(+)CD25(+) T cells by increasing Foxp3 demethylation in lupus CD4(+) T cells. Clin Immunol (Orlando, FL), 143, 180–7